Endpoints News 2. Juni 2026 Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exit
Boston Scientific 2. Juni 2026 FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case - Yahoo Finance
Moderna 2. Juni 2026 ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival - BioSpace
Endpoints News 2. Juni 2026 Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitis
Thermo Fisher 2. Juni 2026 Thermo Fisher Scientific vs Mettler-Toledo International: Which Stock Could Rally? - Trefis
Abbott 2. Juni 2026 ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence - Medical Device Network
Endpoints News 2. Juni 2026 Praxis sinks on late-stage study fail for seizure pill, halts second trial
BioPharma Dive 2. Juni 2026 ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
FierceBiotech 2. Juni 2026 Abivax stock suffers as cancer cases overshadow stellar efficacy in ulcerative colitis phase 3 trial
Endpoints News 2. Juni 2026 Allen Institute launches $200M effort to turn brain atlas lessons into medicines
FierceBiotech 2. Juni 2026 ASCO: Takeda touts ‘tremendous potential’ of Innovent’s PD-1/IL-2 bispecific after seeing survival data
Thermo Fisher 2. Juni 2026 Thermo Fisher Scientific Simplifies Nucleic Acid Verification With New E Gel Power Snap Lite System - BioPharma APAC
Mettler Toledo 2. Juni 2026 Assessing Mettler-Toledo (MTD) Valuation After Recent Short-Term Share Price Momentum - simplywall.st
Luminex 2. Juni 2026 SMi Systems and Luminex: A Partnership to See the Unseen in Diagnostics - BriefGlance